Evidence map›Paper›PMID 26138122›Full record

ArticleStroke2015

Effect of Antibiotic Class on Stroke Outcome.

Dannielle Zierath, Allison Kunze, Leia Fecteau, Kyra Becker

Abstract read
In one paragraph

Article in Stroke, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  2. Article
  3. Review
  4. Article
  5. Impact of Infection on Stroke Morbidity and Outcomes.Current neurology and neuroscience reports · 2016
    Review
  6. Article
  7. Infection and Stroke: an Update on Recent Progress.Current neurology and neuroscience reports · 2016
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dannielle ZierathFrom the Department of Neurology, University of Washington School of Medicine, Seattle.
Allison KunzeFrom the Department of Neurology, University of Washington School of Medicine, Seattle.
Leia FecteauFrom the Department of Neurology, University of Washington School of Medicine, Seattle.
Kyra BeckerFrom the Department of Neurology, University of Washington School of Medicine, Seattle. kjb@uw.edu.
University of Washington · US

Funding

Sensitization to Brain Antigens Following StrokeR01NS056457 · NINDS · UNIVERSITY OF WASHINGTON · PI BECKER, KYRA J · 2006 to 2015
$3.0M
NINDS NIH HHS 5R01NS056457NINDS NIH HHS R01 NS056457
6 · The paper itself

Abstract

background and purposeInfections are common after stroke and associated with worse outcome. Clinical trials evaluating the benefit of prophylactic antibiotics have produced mixed results. This study explores the possibility that antibiotics of different classes may differentially affect stroke outcome.

methodsLewis rats were subjected to transient cerebral ischemia (2 hours) and survived for 1 month. The day after stroke they were randomized to therapy with ceftiofur (a β-lactam antibiotic), enrofloxacin (a fluoroquinolone antibiotic), or vehicle (as controls) and underwent the equivalent of 7 days of treatment. Behavioral tests were performed weekly until euthanization. In a subset of animals, histology was done.

resultsThere were no differences in outcomes at 24 hours or 1 week after stroke among the different groups. At 1 month after stroke, however, performance on the rotarod was worse in enrofloxacin-treated animals when compared with control animals.

conclusionsIndependent of infection, the antibiotic enrofloxacin was associated with worse stroke outcome. These data echo the clinical observations to date and suggest that the secondary effects of antibiotics on stroke outcome should be considered when treating infection in subjects with stroke. The mechanism by which this antibiotic affects outcome needs to be elucidated.

Indexed as

AnimalsAnti-Bacterial AgentsLymphocytesMaleRandom AllocationRatsRats, Inbred LewStrokeTreatment OutcomeAnti-Bacterial Agentsantibacterial agentsbeta-lactamceftiofurfluoroquinolonesstroke

Identifiers

PMID26138122
PMCPMC4519367
OpenAlexW1952029789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.